Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis

Neurology

Volumn 53, Issue 6, 1999, Pages 1361-1363

  Fernandez Arquero, M ^a   Arroyo, R ^a   Rubio, A ^a   Martin, C ^a   Vigil, P ^a   Conejero, L ^a   Figueredo, M A ^a   De La Concha, Emilio Gómez ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Gene association; HLA class II; MS; Polymorphism; Tumor necrosis factor

Indexed keywords

HLA ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0032880710     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.6.1361     Document Type: Article

References (10)

1. Bell JI, Lathrop GM. Multiple loci for multiple sclerosis. Nat Genet 1996;13:377-378.
2. Hauser SL. Tumor necrosis factor: immunogenetics and disease. Ann Neurol 1995;38:702-704.
3. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
4. Weinshenker BG, Wingerchuk DM, Liu Q, Bissonet AS, Schaid DJ, Sommer SS. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology 1997;49:378-385.
5. Brinkman BM, Huizinga TW, Kurban SS, et al. Tumour necrosis factor-α gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997;36:516-521.
6. De la Concha EG, Arroyo R, Crusius JBA, et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing-remitting multiple sclerosis. J Neuroimmunol 1997;80:172-178.
7. Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG. A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology 1997;49:626-628.
8. Huizinga TW, Westendorp RG, Bollen EL, et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997;72:149-153.
9. Marrosu MG, Murru MR, Costa G, et al. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 1997;61:454-457.
10. Moghaddam PH, de Knijf P, Roep BO, et al. Genetic structure of IDDM1. Two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Diabetes 1998;47:263-269.